Home  /  Resource Library  /  Older Patients (pts) with Previously Untreated Classical Hodgkin Lymphoma (cHL): A Detailed Analysis from the Phase 3 ECHELON-1 Study

Older Patients (pts) with Previously Untreated Classical Hodgkin Lymphoma (cHL): A Detailed Analysis from the Phase 3 ECHELON-1 Study

Results of a phase III study investigating Brentuximab Vedotin for first line treatment of elderly patients with Hodgkin lymphoma.